KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gilead Sciences (GILD) Net Income - Minority (2016 - 2021)

Gilead Sciences filings provide 11 years of Net Income - Minority readings, the most recent being -$7.0 million for Q2 2021.

  • On a quarterly basis, Net Income - Minority rose 93.91% to -$7.0 million in Q2 2021 year-over-year; TTM through Jun 2021 was -$7.0 million, a 93.91% increase, with the full-year FY2020 number at -$19.0 million, up 84.8% from a year prior.
  • Net Income - Minority hit -$7.0 million in Q2 2021 for Gilead Sciences, up from -$12.0 million in the prior quarter.
  • In the past five years, Net Income - Minority ranged from a high of -$7.0 million in Q2 2021 to a low of -$476.0 million in Q1 2017.
  • Median Net Income - Minority over the past 5 years was -$120.0 million (2019), compared with a mean of -$144.2 million.
  • Biggest five-year swings in Net Income - Minority: tumbled 149.15% in 2018 and later skyrocketed 93.91% in 2021.
  • Gilead Sciences' Net Income - Minority stood at -$59.0 million in 2017, then tumbled by 149.15% to -$147.0 million in 2018, then rose by 14.97% to -$125.0 million in 2019, then surged by 84.8% to -$19.0 million in 2020, then surged by 63.16% to -$7.0 million in 2021.
  • The last three reported values for Net Income - Minority were -$7.0 million (Q2 2021), -$12.0 million (Q1 2021), and -$19.0 million (Q4 2020) per Business Quant data.